5-doxylstearate and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

5-doxylstearate has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for 5-doxylstearate and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin. Research communications in molecular pathology and pharmacology, 1994, Volume: 85, Issue:2 The incubation of K562 cells with adriamycin resulted in a decrease in cell membrane fluidity as measured by electron spin resonance using the paramagnetic probe 5-doxylstearic acid. Coincidently, the antiproliferative effect of adriamycin was progressively inhibited as the concentration of adriamycin was increased. The results indicate that adriamycin induces changes in the plasma membrane of K562 cells after exposure to a low level of this agent. Topics: Cyclic N-Oxides; Doxorubicin; Electron Spin Resonance Spectroscopy; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Fluidity; Spin Labels; Tumor Cells, Cultured	1994

Article

Year

Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin.

Research communications in molecular pathology and pharmacology, 1994, Volume: 85, Issue:2

The incubation of K562 cells with adriamycin resulted in a decrease in cell membrane fluidity as measured by electron spin resonance using the paramagnetic probe 5-doxylstearic acid. Coincidently, the antiproliferative effect of adriamycin was progressively inhibited as the concentration of adriamycin was increased. The results indicate that adriamycin induces changes in the plasma membrane of K562 cells after exposure to a low level of this agent.

Topics: Cyclic N-Oxides; Doxorubicin; Electron Spin Resonance Spectroscopy; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Fluidity; Spin Labels; Tumor Cells, Cultured

1994